Introduction
Curcumin,i solated from al ocal plant in Asia and also known as the golden spice, is frequently used as af ood additive. Chemically,t he structure of curcumin features two vanillylidene groups,k eto-enol tautomerism, and ac onjugated system (Figure 1 ), and this molecule was successfully prepared for the first time in excellent yield by Pabon in 1964 . [1] In that respect, the use of boron complexed with acetylacetonew as shown to produce symmetrical curcumin derivatives efficiently. Since then, severalp ublications have described how this procedure can be to appliedt op repare ad iversity of related target compounds. [1, 2] From ab iological point of view,c urcumin displays multiple activities, especially in the field of oncology.
[3] Moreover,c urcumin has long been considered to be an ideal compound to treat cancer duet os everalr eports highlighting its nontoxicity for mammals, even at high doses.
[4] Despite the established benefits of curcumin, it still suffers from limited bioavailability,f ast metabolismi nt he body,a nd rather aspecifica ctivity.
[5] To circumventt hesep roblemsa nd to improve its pharmacological properties, many reported approaches focus on the introduction of structuralm odifications of the curcumin scaffold to deliver new analogues. [6] In that respect, previous work in our group aimed at the preparation of nitrogen curcumin analogues and involved modification of the labile b-diketone moiety by synthesizing new b-enaminone curcuminoids by using both alkylamines and more polar Curcumin,anatural compound extractedf rom the rhizomes of Curcuma longa,d isplays pronounced anticancer properties but lacks good bioavailability and stability. In ap revious study,w e initiated structure modification of the curcumin scaffold by imination of the labile b-diketone moiety to produce novel b-enaminone derivatives. Thesec ompounds showed promising properties for elaborate follow-up studies. In this work, we focused on another class of nitrogen-containing curcuminoids with as imilaro bjective:t oa ddresst he bioavailability and stability issues and to improve the biological activity of curcumin. This paper thusr eports on the synthesis of new pyridine-, indole-,a nd pyrrole-based curcumin analogues (aza-aromatic curcuminoids) and discusses their water solubility,a ntioxidant activity,a nd antiproliferative properties. In addition, multivariate statistics, including hierarchical clustering analysisa nd principal component analysis, were performed on ab road set of nitrogen-containing curcuminoids. Compared to their respective mother structures, that is, curcumin and bisdemethoxycurcumin,a ll compounds, and especially the pyridin-3-yl b-enaminone analogues,s howed better water solubility profiles. Interestingly, the pyridine-, indole-, and pyrrole-based curcumin derivatives demonstrated improved biological effects in terms of mitochondrial activity impairment and protein content, in addition to comparable or decreased antioxidant properties. Overall, the biologically active N-alkyl b-enaminone aza-aromatic curcuminoids were shown to offer ad esirable balance between good solubility and significant bioactivity.
amines. [7] The obtained N-alkyl b-enaminones showed higher cytotoxicity than curcumin, but similarw ater solubility.O nt he other hand, more polar b-enaminonec urcumin derivatives displayed significantly improved water solubility and comparable bioactivities against undifferentiated cancer cells, in addition to no toxicity against differentiatedi ntestinal cells. The rationale to introduce a b-enaminone moiety was relatedt ot he broad biological relevance of b-enaminonesi ng eneral, including for example, antimicrobial, [8] anticonvulsant, [9] and antitumor/anticancer properties. [7, 10] Up to now,t he replacement of the aromatic moiety of curcumin with an azaheteroaromatic alternative-another way to introduce nitrogen-has been rarely envisaged in curcumin chemistry.O nly af ew isolated examples have been reported in the literature so far, [11] and these compounds are poorly documented in terms of their synthesis, characterization, physical properties, and bioactivities.T herefore, in this work, as et of new azaheteroaromaticc urcumin analoguesw as synthesized to address the low water solubility of curcumin, withoutc ompromising its pronouncedb ioactivities.B ecause of the good results obtained previously for b-enaminone derivatives, b-enaminone aza-aromatic curcuminoids were synthesizeda sw ell by using different amines.A ll of these new azaheteroaromatic analogues were evaluated in an ext stadiumf or their in vitro biological behavior,w ater solubility, and antioxidant capacity. Finally,m ultivariate statistics were performed on ab road set of nitrogen-containing curcuminoids to shed more light on structure-property relationships.
Results and Discussion
In this work, azaheteroaromaticc urcumin analogues were successfully prepared by using carefullyo ptimizedr eactionc onditions (TableS1, SupportingI nformation). Three different aldehydes were selected to synthesize the desired structures:p yridine-3-carboxaldehyde, indole-3-carboxaldehyde, and pyrrole-2-carboxaldehyde. Boron complexation (B 2 O 3 )w ith acetylacetone (1)w as deployed to protect the active methylene unit and to avoid the typical side reaction (i.e. formationo faC3 Knoevenagel product). The reactions were performed in ethyl acetate at 80 8Cf or at least 4hand were monitored by TLC or LC-MS to reach maximum conversion.R elative to the reaction time required for bis-pyridine 2 (4 h), longerr eactiont imes were required for bis-indole 3 (20 h) and bis-pyrrole 4 (18 h) to obtain the desired products in yields of 9a nd 20 %, respectively (Table S1 ). However,f or compounds 3 and 4,t he reaction was alternatively performed in acetonitrile by using piperidine as ab ase, whichp rovided improved yields of 49 and 66 %, respectively (Scheme 1). To obtain the pure products, the crude mixtures were purified by silica gel column chromatography followed by recrystallization from methanol. Subsequently, bispyridine 2 was selected to be used in the synthesis of the corresponding b-enaminone derivatives. As established in our previous studies, the use of montmorillonite K10 (MK10), in combination with microwave irradiation, providesac onvenient methodt op repare b-enaminone curcuminoids. [7] Thus, the proposed imination of structure 2 was performeda ccordingly with either methoxyalkyl-, hydroxyalkyl-, or alkylamines (RNH 2 ) and 2.4 equivalents of acetic acid in the presence of MK10 (Scheme 2, Table 1 ). Several attempts were madet oo ptimize the reactionc onditions towards the synthesis of b-enaminone pyridin-3-yl curcumin analogues 5a-f.T he reactionw as conducted in 2-methyltetrahydrofuran (2-MeTHF) or ethanol at 80-85 8Cf or 75-105 min. Althoughf ull conversion was always reached, the amounto fa mine added (2.5-10 equiv) had to be optimized for each amine separately.I ns ome cases, polar amines triggered the formationo fc yclic side products (i.e. compounds 6d and 6f), for which the reaction mechanism is described in previousw ork.
[7b] The ratio of b-enaminones 5d or 5f versus dihydropyridin-4-ones 6d or 6f was found to be 1.5-2.3/1 (Scheme 2). Al ongerr eactiont ime (105 min) apparently stimulated this cyclization reaction, and as described before,the use of ethanolw as also observed to activate pyridinone formation under microwave irradiation (Table 1) .
[7b]
The obtained curcuminoids weret hen purified by column chromatographyt oo btain compounds 5a-f, 6d,a nd 6f in rather low yields (6-24 %) but excellent purity.A sc an be noticed, as ubstantial amounto fp roduct was inevitably lost during either normal-or reverse-phase column chromatography.
Scheme1.Synthesis of azaheteroaromatic curcumin analogues 2-4.
Scheme2.Synthesis of b-enaminones 5a-f and cyclic products 6d and 6f. With the aim to improvet he water solubility and bioactivity and to extend the availablec ompound library,n ew azaheteroaromatic curcumin analogues 2-4, b-enaminone analogues 5a-f,a nd dihydropyridin-4-ones 6d and 6f were thus produced in this work. All compounds had ap urity of ! 95 %, which wasd etermined by NMR spectroscopy and LC-MS analysis. Afterwards, these molecules were examined in terms of their water solubility to support the rationaleo ft his work. The main reasonb ehind the applied structure modification was to improvet he solubility and hence to avoid in vitro precipitation of compound dilutions andm ore specifically to increase their bioaccessibility (because higher aqueouss olubility usually results in better oral bioavailability). Curcuminoids may be absorbed through the gastrointestinal tract through ac ombination of processes including passive diffusion and active transport. In that respect, the water solubilityo fc ompounds 2-6 was analyzed by using ac olorimetric technique-based assay at two differentt ime points( 90 min and 24 h) to make sure that the solubility values reached the maximumc oncentration for each compound.A ne xcessa mount of solid was dissolved in a phosphate buffer at pH 6.8 by using the shake flask method, which is commonly used to determine aqueous solubility. [7b, 12] The experiments were designed for 24 ha t3 78Ca verage body temperature. The valuesw ere obtained on the basis of linear regressiono fe ach standard curve, which was independently triplicated. The results show that the solubilities of modified compounds 2-6 are all higher than that of curcumin,ass hown in Ta ble 2. Specifically,a za-aromaticc urcumin analogues showeda3-to 28-fold increasei nw ater solubility,w hereas pyridine-based b-enaminone curcumin analogues 5a-f demonstrated significantly improveds olubility in the range of 4-to 1600-fold. Specifically, b-enaminones with polar amines displayed extremelyh igh aqueous solubility. Moreover,c ompounds 6d and 6f showed high water solubility in buffer medium, in the same range as that of their respective b-enaminones 5d and 5f.T hese results imply that the modification successfully addressed one of the main goals of our work, which was to obtain derivatives with improved aqueous solubility. [7] Therefore, these resultsc an contribute to minimized precipitation issues in ab iological mediumf or anticancer evaluation,which is beneficial within the framework of bioavailability studies.
Because curcumin is known to exert interesting antioxidant activities, the antioxidant properties of the newly synthesized azaheteroaromaticc urcumin analogues were determined by using the DPPH (1,1-diphenyl-2-picrylhydrazyl) radical-scavenging activity assay and the ferric reducing antioxidant power (FRAP) assay.
[13] Trolox and a-tocopherolw ere used as antioxidant positive controls (for the DPPH and FRAP assays, respectively).T he DPPH and FRAP assays are commonly used primarily to evaluate the chemical antioxidantp roperties. The DPPH scavenger assay is based on the neutralization of the stable DPPH radicala nd determines the percentage inhibition of radical activity.O nt he other hand, the FRAP assay is based on the reduction of the ferric(III)-tripyridyltriazine complex (Fe 3 + -TPTZ)t ot he ferrous form (Fe 2 + -TPTZ) and is expressed as Trolox equivalents. The resultso ft he chemical antioxidant capacity tests are described in Ta ble 1. From all aza-aromatic curcumins, bis-pyridine 2 showedn oa ctivity,whereas compounds 3 and 4 could not be evaluated by the DPPH assay due to the saturation of the selected wavelength (l = 515 nm) for this experiment (see the Supporting Information). Therefore, an alternative method wasd eployed (using FRAP), and bis-pyrrole 4 (0.79 Trolox equivalent per mm)s howeda ctivity comparable to that of a-tocopherol,w hereas bis-indole 3 (0.27 Trolox equivalent per mm)s howed antioxidantp ropertiest hat were lower than those of the controls. This could be explained by the fact that the free NH functionality on the azaheteroaromatic ring can be equipotent to the hydroxy groupsint he curcumin scaffold. Compounds 5 and 6 showed no/lower antioxidant activity than curcumin and the positive controls, probably because these structuresd on ot contain ah ydroxy group on the pyridinyl curcumin core. Compounds 5e and 5f,c ontaining ah ydroxy moiety in the b-enaminone nitrogen substituent, showed slightly lower activity upon the FRAP experiment (0.04 Trolox equivalent per mm), whereas the median effective concentration (EC 50 )v alues under the highest concentration (200 mm)c ould not be observed as explicitly upon performing the DPPH experiment. The lack of phenolic groups (due to the replacement of the aromatic part of curcumin with ap yridin-3-yl scaffold) resulted in complete abolition of the antioxidant activity in both assays,w hichf urthers upports the established importance of the free phenolic( or amino)g roups if antioxidant properties are desired.
Next to these antioxidant properties, curcuminoids have shownawider ange of other biological activities, in particular anticancer effects.
[3b, d, f, 14] Therefore, different cell lines were subjected to newly synthesized nitrogen curcuminoids 2-6 and were analyzed throughi nvitro cell-based assays for protein content as am arker for cell growth (sulforhodamine B, SRB), mitochondriaa ctivity [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, MTT],a nd intracellular reactive oxygen species( ROS) production( 2 ',7'-dichlorodihydrofluores- values, strongly depending on the cell type. Interestingly,a zaaromatics 2-4 showed higher mitochondrial activity/growthi nhibition( MTT) than their mother compound curcumin. To support these results, ap rotein contente xperiment (SRB) was then performed, and the results pointedt ot he same trend as that observed for the MTT assay,w hichc onfirmed that azaheteroaromatic analogues 2, 3,a nd 4 exhibit significantly stronger cell growth inhibition effects than curcumin.O nt he other hand, b-enaminones 5a-d demonstrated moderate growth inhibition, whereas 5e and 5f showedn oa ctivitya tm aximum concentration( 75 mm). In terms of their water solubility, b-enaminones 5a-f performed better than azaheteroaromatic analogues 2-4 and curcumin. No solids were observed after an incubation time of 72 hf or the MTT andS RB assays for compounds 5a-f.T hus, it seems that the more soluble compounds exert decreased cytotoxicity due to al ow cell membrane permeability effect, whichw ill be elaborated furthero n. Moreover, dihydropyridin-4-ones 6d and 6f showedatrend similart o that shown by 5e and 5f concerning their bioactivitya nd water solubility.T hus, the aim to improvew ater solubility was successfully reached for all structures, whereas the bioactivity towardsc ancer cells was slightly lower for b-enaminones 5a-f and considerably higher for aza-aromatics 2-4.I nc ontrast, dihydropyridin-4-ones 6d and 6fshowed no interesting cytotoxicity,p ointing to the importance of conserving the linear curcumin scaffold if cancerc ell proliferation is targeted.T hus, the introduction of an itrogen atom in the aromatic moiety of the curcumin scaffold has ap ositive influence on the antiproliferative properties of curcumin, provided that the conjugated curcumin structure remains intact. Although azaheteroaromatic benaminones 5a-f,especially the most polar ones, showslightly lower (yet still significant) cytotoxic effects than non-b-enaminone templatec ompound 2,t he installation of a b-enaminone moiety is desired, because this increases the stability of the curcumin scaffold. [7b, 15] In other words, further optimization of this class couldf ocus on minor modifications of the nitrogen side chain to arrive at compounds with even better bioactivity, water solubility,a nd stability. Within our series of six azaheteroaromatic b-enaminone derivatives, compound 5a demonstratedt he highest antiproliferativea ctivity-almost comparable to the activityo fc urcumin-and will therefore be used as al ead compound for the synthesis of new b-enaminones in future work.
In the next set of experiments, intracellular ROS was assessedi nd ifferent cell lines because of their possible role in cytotoxicity-related pathways. Thei mbalance between ROS and antioxidant levels could lead to the development of cell damage and health issues, including chronic diseases. [16] Higher ROS levels are considered as toxic and sequentially cause DNA damage and, therefore, increase the risk in the first stage of cancer development. [17] Moreover,h igh ROS production may also causec ell apoptosis by stimulation of the intrinsic mitochondrial pathway,w hich induces outer membrane permeabilization and releases apoptotic proteins. [18] An antioxidant diet, rich in polyphenols, can trigger ar eduction in the amount of ROS produced, which is consequently beneficial for treating severalh uman diseases, including neurodegenerative diseases, [19] aging, [20] inflammatory injuries, [21] and cancer. [22] It is worth considering whether the observed cytotoxicity of curcuminoidsm ay be correlated to the induction of intrinsic mitochondrial pathways by high ROS production. It is possible that the a,b-unsaturated ketonem oiety can serve as ab iological Michael acceptor that covalently binds to the thiol residues (SH) of cysteinecompartments in differentproteins and initially Table 3 . Cell growth inhibition of 2-4, 5a-f, 6a,a nd 6b measured after 72 ht reatment by using mitochondria activity (MTT) and protein content (SRB) assays.
[a]
CompdCaco-2I C 50 
[a] Data are presented as mean AE standard deviation.C ombination data of MTT and SRB from two different students on curcumin analogues (n ! 6).
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www.chemistryopen.org 2018 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim triggersc ascade signaling apoptosis pathways. [23] To study the impact of novel derivatives 2-6,afluorescent-based technique was conducted by using DCFH-DA, which is commonly used as ap robe foroxidative stress.Int his work, two concentrations of curcuminoids were tested, 10 (high) and1mm (mild), and they parallelp lasma concentrations of curcumin in ap revious study. [24] Moreover,R OS experiment resultsw ere analyzed in correlation to protein content (SRB) to normalize the ROS productionv alues, asf ormerly observed MTT and SRB values showedt hat some IC 50 values were lower than 10 mm.M oreover,a sp reviously reported, the ROS response in the EA.hy926 cell line was pro-oxidative, [7a] whereas for intestinal cell lines (Caco-2a nd HT-29), intracellular ROS response was decreased in some cases. In both HepG2 and CHO-K1, some compounds had an antioxidative effect. [7] In this study,a t1 0mm treatment, aza-aromatics 2-4 all showedastrongr esponse (intracellular ROS products) in the five different cancer cells, whereas at 1 mm,b is-indole 3 demonstrated increased ROS productioni n two different cell lines, HT-29 and HepG2.M oreover,bis-pyrrole 4 exhibited at rend similart ot hat exhibited by compound 3 but on differentc ells, Caco-2 and EAhy926,w hereas decreased ROS generation was observed in HepG2 (indicating an antioxidant effect). For b-enaminones 5a-f,t he increase/decrease in ROS depended on the cell type. In Caco-2, compounds 5a-e showedm oderate to high ROS generation at 10 mm,w hereas no increase/decrease in ROS production could be noticeda t 1 mm.I nc ontrast, in EAhy.926 and CHO-K1c ells, the ROS response slightly decreased upon applying 5a-c, 5e,a nd 5f independently at 1 mm.M oreover,H T-29 and HepG2c ells, at 10 mm,w ere observed to provoke an antioxidant effect that minimized ROS productionf or 5a-c, 5e,a nd f.F or dihydropyridin-4-ones 6d and 6f,R OS production was not remarkably visible in five different cell lines at both concentrationsr elative to that observed for nontreated cells. Ac ontrol in these experiments was NAC, aR OS inhibitor, [25] which induced as ignificant decreasei nR OS generation in the intestinal cell lines (Caco-2 and HT-29), the endothelial cell line (EA.hy926), and the hepatoma cell line (HepG2). An increase was only observedi nC HO-K1 cells, as shown in Ta ble 4. It is often difficult to comparer esults with other studies because of the different parameters used in the experimental procedures,s uch as cell line types, molecules, concentrations, and incubation periods.
[26] To our interpretation, increased cellular ROS was observed at a1 0mm concentrationf or bis-indole 3 and bis-pyrrole 4 in fivedifferent cell lines,whereas bis-pyridine 2 showed at rend similar to that of the other two aza-aromatic curcuminoids, except in HepG2 cells. The reason behind the different resultsi nH epG2 cells may be relatedt ot heir robustness and detoxification mechanisms. [27] Moreover, b-enaminones 5a-f showedi ncreased cellular ROS in Caco-2 at 10 mm,w hereas other cell lines were observed to display either decreased cellular ROS or no difference relative to nontreated cells (control). At 10 mm,c ompounds 5c, 5d,a nd 5f exhibited significantly decreased ROS in HepG2 cells, whereas compounds 5a-c showedd ecreased ROS in HT-29 cells. At 1 mm,i nE A.hy926, decreasedR OS generation was observed in 5b, 5c,a nd 5f,w hereas in compounds 5a-c, 5e, and 5f it was observed in CHO-K1c ells. However,d ihydropyridin-4-ones 6d and 6f showed no activity at both test concentrations( 10 and 1 mm). Therefore, our results remarkably demonstrate the pro-oxidative effect of aza-aromatic curcumin analogues 2-4,w hereas b-enaminones 5a-f show both pro-oxidative and antioxidativee ffects depending on the cell types. It can be concluded that there might be ac orrelation between the cytotoxicity effects of aza-aromatics 2-4 and overproduction of ROS, which was preliminaryo bserved in MTT and SRB, suggesting that these compounds induce cytotoxic effects through ROS-mediated apoptosis pathways. Nonetheless, in the case of b-enaminones 5a-f and dihydropyridin-4-ones 6d and 6f,n oe xplicit link can be noted between cell viability and pro-or antioxidant activities, and other pathways might be in play as well. In these cases, the increased/decreased intracellular ROS levels were strongly cell line/compounds pecific.
To allow am ore thorough interpretation of the results obtained by screeningo ft he b-enaminone analogues and dihy- Table 4 . Intracellular ROS, expresseda spercentage compared to the untreated control cells (n ! 3) with protein content normalization (ROS/SRB).
Compd
Caco-2 EA.hy926HT-29 HepG2 CHO-K1 92.8 AE 5.8 [b] 84.2 AE 8.1 [b] 95.9 AE 13.8 91.9 AE 5.2 [b] 88.7 AE 16.2 N-acetyl-lcysteine 47.8 AE 2.6 [c] 55.7 AE 5.8 [c] 79.6 AE 7.4 [b] 79.6 AE 11.1 [b] 87.7 AE 3.7 [b] 90.1 AE12.0 [b] 70.5 AE 3.1 [c] dropyridin-4-ones (produced during current and previous studies), [7] multivariate statisticsi ncluding hierarchical clustering analysis( Figure S2 ) and principal component analysis were used to find correlationsb etween the chemical structures and biological activities and to suggest suitable side chainsf or good antiproliferativea ctivity. [28] These analyses were applied to curcumin (Cur), bisdemethoxycurcumin (Bis), pyridin-3-yl curcuminoid 2,a nd acetylated curcumin as the motherc ompounds for b-enaminones and dihydropyridin-4-ones (32 derivatives, Figure 2a) . The multivariate statisticswere computationally performed using the SPSS program (version 24). [29] To gather more information, principal component analysis (PCA) was performed to revealt he structural features of their activity. Thus, af actoriala nalysis (PCA) was also performed in SPSS statistics. It was observedt hat the two major principle components explained 46 %o ft he variance between the different compounds. If the variables are displayed in a2 Dp lot based on these two principal components, we can see that three clustersa re formed. Cluster 1c ontains antioxidanta ctivity and ROS activity for the CHO-K1 and EA.hy926 cell lines. Cluster 2 consists of the MTT data of all cell lines, andc luster3contains water solubility and ROS data of the intestinal Caco-2 and HT-29 cell lines. On the basis of these results, we may suggest that the biological behavior of the curcuminoids is mainly driven by water solubility (PCA1, 30.6 %o fv ariance) and (anti-) oxidant activity (PCA2,1 5.9 %o fv ariance). Secondly,w hereas the MTT data are similar betweenc ell lines, clear cell line dependentb ehavior is visible for the intracellular antioxidant capacity,b ecause the ROS data for intestinal and nonintestinal cells are positioned in opposite fields along the PCA1 axis, which may correspond with water solubility.W eh ypothesize that for nonintestinalc ell lines, PCA1 (corresponding with solubility) determinest he anticancer activity because viability (MTT) and ROS are in two opposite fields in the plot along the PCA1 axis. On the basis of existing literature, this may be explained by the absorption characteristics of the compound, which may be dominated by passived iffusion, [30] as hydrophobic compounds are more absorbed throught he cell membrane.H owever,f or intestinal cell lines, it is PCA2 (corresponding with the antioxidant activity of the compounds) that triggers the anticancer effect because viability and ROS are positioned in oppositef ields along this axis. This can be explained by the fact that intestinal cells are quite robusta nd have ad iversity in transporters for phenolics, [31] so that hydrophobicity is not exclusively necessary forb ioavailability.I ft he compounds are displayed in a2 Dp lot based on these two princi- pal components, we see that PCA1 (solubility) triggerst he separation of the compounds by the hydrophilicity of the side chain, as nonpolara liphatic b-enaminones are clustered in the left space and polar aliphatic b-enaminones are clustered in the right space.H ence, these hydrophobic side chains mainly have an anticancer effect on EA.hy926 and CHO-K1 cells. For hydrophilic side chains, the effect is mainly triggered by PCA2 (antioxidant capacity) in intestinal cells. This can be explained by the presence of either av anillyl or 4-hydroxyphenyl moiety in the targeted compounds( polar andn onpolar side chains), which contain hydroxy groups displaying antioxidant properties. To maintain the antioxidant capacity,w es uggest that a compound that contains ap henolic moiety should be constructed, asi tm ay provide better activity.O nt he basis of the latter plot, two possibilities to improveb ioavailability or bioactivity can be proposed.T he first one is that polar amines can increasew ater solubility,w hich may be linked to better/poor bioavailability (cell dependence);t he second one is that alkylamines can increase cytotoxicity (low IC 50 values), which may be linked to higherb ioactivity in terms of antiproliferative effects and ROS induction. To investigate the impacto fs ide chains and the aromatic moiety as key elements in terms of stability and water solubility improvement in biological media, we display the curcuminoids by the substituted side chains in Figure 2a ,c.C ompounds 5c-f, 6d, 6f, 8i, 9a,a nd 9b,s ubstituted by either am ethoxy-or hydroxyalkylamine, are clustered together in the right space (Figure 2c ), generally providing high solubility and high cytotoxicity. Remarkably,c yclohexyl/isobutyl-substituted b-enaminones (5a, 5b, 7b, 8c, 8f, 8k, 8l,a nd 8m)s howed better activity than curcumin, withs lightly improvedw ater solubility (5a, 7b, 8c, 8f, 8k, 8l,a nd 8m)o r better solubility (5b). Moreover, compounds 7a, 7c, 7d, 8d, and 8e showeda ctivity comparable to that of motherc ompounds Cur and acetylated curcumin, with moderately improvedw ater solubility.B esides, 8a and 8b demonstrated bioactivity that was better than or comparable to that of curcumin (Cur). On the other hand, dihydropyridin-4-ones 6d, 6f, and 9a-c,b earing polar aliphatic side chains, are distributed in the right space (PCA1, solubility) without exhibiting any activity relative to their mother compounds( Cur,B is, and 2). Moreover, b-enaminones 5c-f, 8g-j,a nd 8o--q,b earing polar aliphatic side chains, showed moderate to good water solubility with either comparable or lower activity.T his information could suggest that alkyl side chains (n-propyl, n-butyl, allyl, isobutyl, sec-butyl, andc yclohexyl),a sd emonstrated in our b-enaminone research, [7] could be of benefit for further investigation of curcumin by using as imilarp latform. The improvement in water solubility is an important factor to address the classical problem of curcumin, but compounds that show high solubility could have compromised biological activity.T hisc ould imply that polar b-enaminones cannot pass the hydrophobic cell membrane of intestinal cells, therebyl eadingt ol ow cytotoxicity. [32] Nevertheless, b-enaminone analogues display improvedc ompound stability, which addresses another problem related to curcumin.
Conclusions
In summary,w es uccessfully synthesized 2-4 as three new (pyridine-,i ndole-, and pyrrole-based) azaheteroaromaticc urcumin analogues and 5a-f as six novel azaheteroaromatic benaminones. To obtain pyridine b-enaminone analogues 5,a n optimized microwave irradiation approach was performed by using montmorillonite K10 clay.I ns ome cases, this method also provided access to dihydropyridin-4-ones 6d and 6f by cyclization.A se xpected on the basis of previouso bservations, the installation of the central b-enaminone moiety en route to N-alkyl or N-hydroxy/methoxyalkyl b-enaminone derivatives 5 (significantly) increased the water solubility relative to thato f the parentc ompound. Moreover,t he water solubility of azaheteroaromatic curcumin derivatives 2-4 was also slightly increasedr elative to that of curcumin. Biologically,t hree new aza-aromatic curcumin derivatives (i.e. compounds 2-4), six benaminones (i.e. compounds 5a-f), and two dihydropyridin-4-ones (i.e. compounds 6d and 6f)w ere evaluatedf or their intracellulara nd chemical antioxidant properties and their cytotoxicity. Bis-indole 3 and bis-pyrrole 4 showedm oderate antioxidantp roperties compared to curcumin (according to the ferric reducing antioxidant powera ssay), whereas bis-pyridine 2 did not. Cell-based experiments were performed by using five different cancerc ell lines (HepG2,E A.hy926, Caco-2, HT-29, and CHO-K1). With regard to the mitochondrial activity and protein content,a zaheteroaromaticc urcumin derivatives 2-4 showedh ighera ctivity than curcumin, and in some cell lines they showed activity comparable to that of the positive control doxorubicin. New pyridine b-enaminones 5a-f proved to have either moderate bioactivity or bioactivity comparable to that of curcumin. As ar esult of intracellular ROS generation,a zaheteroaromatic curcumin compounds 2-4 showed as ignificant increasei ni ntracellular ROS production, suggesting that these molecules may induce cytotoxic effects through ROS-mediated apoptosis pathways. On the other hand, compounds 5a-f showeds light increases or decreases in ROS generation, whereas pyridinones 6d and 6f displayedn os ignificant ROS variationc ompared to nontreated cells. In this work, we initiated av aluable incentive for exploring new curcumin analogues bearingd ifferent azaheteroaromaticand b-enaminone moieties that could lead to promising candidatesi nt he framework of oxidative-related stress disease developments. Moreover,a structure-activity relationship study using multivariate statistics analysiss howed that nonpolar aliphatic side chains demonstratedb etter activity than polar aliphatic side chains, which explicitly relatest ot heir water solubility profiles. The highly soluble b-enaminone derivatives (bearing ap olar aliphatic moiety) showed an inverted relationship concerning cytotoxicity.T herefore, on the basis of our results, we suggest that aliphatic amines (allyl, n-butyl, isobutyl, sec-butyl, n-propyl,c yclohexyl) should be used for furtherd evelopment to contribute to curcumin medicinal chemistry.B iologically active N-alkyl benaminone aza-aromaticc urcuminoids thus offer ad esirable balanceb etween good solubility and significant bioactivity. 13 CNMR spectra were recorded at 100.6 MHz (Bruker AvanceIII Nanobay) with CDCl 3 , [ D 6 ]DMSO, or [D 4 ]methanol as solvent. Low-resolution mass spectra were recorded by injection with an Agilent 1100 Series LC/MSD type SL mass spectrometer with electrospray ionization (ESI, 70 eV) and by using am ass-selective detector (quadrupole). Upon analyzing crude reaction mixtures, the mass spectrometer was preceded by aH PLC reverse-phase column with ad iode array UV/Vis detector.H igh-resolution mass spectra were obtained with an Agilent Te chnologies 6210 time-of-flight mass spectrometer (TOFMS) equipped with ESI/APCI-multimode source. IR spectra were measured with aF ourier-transform infrared spectrophotometer (The IRaffinity-1S). Melting points of crystalline compounds were measured with aK ofler Bench, type WME Heizbank of Wagner &M unz. Microwave reactions were performed with aC EM Discover microwave at fixed temperature. The purity of all tested compounds was assessed by 1 HNMR spectroscopy and/or HPLC analysis, confirming apurity of ! 95 %.
Representative Procedure for the Synthesis of Aza-Aromatic Curcumins 2-4
Acetylacetone (1;2 0mmol, 2.04 mL) was added to as olution of B 2 O 3 (696 mg, 20 mmol, 1equiv) in ethyl acetate or acetonitrile (60 mL). This mixture was stirred at 50 8Cf or 1h.T hen, pyridine-3-carboxaldehyde (3.75 mL, 40 mmol, 2equiv) and tributyl borate [n(BuO) 3 B; 6.53 mL, 40 mmol, 2equiv] were added, and the mixture was further stirred at 50 8Cf or 10 min. Afterwards, either n-butylamine (0.99 mL, 10 mmol, 0.5 equiv) or piperidine (0.99 mL, 10 mmol, 0.5 equiv) in ethyl acetate or acetonitrile (10 mL) was added dropwise over 1h,a fter which the mixture was stirred until the reaction reached maximum conversion at 80 8C, as determined by LC-MS.
For EtOAc as the solvent, after cooling to room temperature, 20 % aq acetic acid (100 mL) was added, and the mixture was further stirred at room temperature for 1h.T he mixture was then washed with as aturated solution of sodium bicarbonate (3 50 mL), and the aqueous phase was extracted with ethyl acetate (2 30 mL). The combined organic phase was washed with water and then dried (magnesium sulfate), filtered, and concentrated under reduced pressure. Column chromatography (SiO 2 ,E tOAc/MeOH 19:1) afforded compound 2 (5.56 g, 50 %). Upon using acetonitrile, boron decomplexation was first performed for 1h followed by evaporation and washing with as aturated solution of sodium bicarbonate to quench the excess amount of acid and to obtain a dark red solid. The dark red solid was then subjected to purification by reverse-phase column chromatography (acetonitrile/water, gradient conditions from 30 to 100 %) to obtain the pure compound. As imilar procedure was then applied for compounds 3 and 4 by using indole-3-carboxaldehyde and pyrrole-2-carboxaldehyde, respectively. Representative Procedure for the Synthesis of b-Enaminones 5a-f and Dihydropyridin-4-ones 6d and 6f
(1E,4Z,6E)-5-Hydroxy-1,7-di(pyridin-3-yl)hepta-1,4,6-trien-3-one (2; 1mmol, 278 mg) was dissolved in 2-MeTHF (5 mL) in a1 0mLm icrowave tube. To this, montmorillonite clay (MK10;5 56 mg, 2equiv mass) was added as an activator.I sobutylamine (0.50 mL, 5mmol, 5equiv) and acetic acid (0.14 mL, 2.4 mmol, 2.4 equiv) were then added, and the mixture was stirred at 80 8Cf or 75 min under microwave irradiation. At the end of the reaction, the mixture was filtered over Celite, and the filter cake was thoroughly rinsed with ethanol (300 mL). The filtrate was then concentrated under reduced pressure until about 30 mL of ethanol remained. Then, ethyl acetate (300 mL) was added, and the mixture was washed with as aturated solution of sodium bicarbonate (50 mL). The aqueous phase was washed with ethyl acetate (2 30 mL). The combined organic layer was washed with water,d ried (magnesium sulfate), filtered, and concentrated under reduced pressure. Column chromatography (SiO 2 ,E tOAc/MeOH 9:1) afforded (1E,4Z,6E)-5-isobutylamino-1,7-di(pyridin-3-yl)hepta-1,4,6-trien-3-one (5a;7 9.9 mg, 24 %). As imilar procedure was then applied for b-enaminones 5b-f and dihydropyridin-4-ones 6d and 6f.T he reactions were performed by using ethanol instead of 2-MeTHF to afford the expected products. The crude products were subjected to purification by normal-phase column chromatography (SiO 2 , EtOAc/MeOH 9:1) to obtain expected compounds 5b, 5c,a nd 5e. For compounds 5d, 5f, 6d,and 6f,reverse-phase column chromatography (acetonitrile/water,g radient conditions from 10 to 100 %) was used to purify to obtain the desired compounds. 
Biological Studies
General MEM nonessential amino acid solution (NEAA), 2,2-diphenyl-1-picrylhydrazyl (DPPH), penicillin/streptomycin (P/S), Trolox, and 2,7-dichlorofluorescein diacetate were purchased from Sigma-Aldrich, whereas 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and trypan blue were obtained from Amresco. Trypsin/ ethylenediaminetetraacetic acid (EDTA) solution and Dulbecco's phosphate-buffered saline (PBS À ,n oc alcium and no magnesium) were obtained from Life Technologies, and fetal bovine serum (FBS) was obtained from Greiner Bio-one. All cell lines, Caco-2 (colorectal adenocarcinoma), HepG2 (hepatocellular carcinoma), CHO (Chinese hamster ovary), HT-29 (colorectal adenocarcinoma), and EA.hy926 (endothelial), were obtained from ATCC. These cell lines were cultivated and maintained in ag rowth medium containing Dulbecco's modified Eagle medium (DMEM) + glutamax, 1% NEAA, 1% P/S, and 10 %F BS. During the MTT experiment, serum-free medium was used to avoid interferences. Each compound or positive control was dissolved in DMSO to prepare the 25 mm stock solution for both cytotoxicity and antioxidant tests. The stock solu- 
Cytotoxicity Activity:MTT Experiments
Throughout the experiment, standard procedures were used to maintain all cell lines at 37 8Cw ith 95 %h umidity and 10 %C O 2 . Using adherent cells, the MTT assay was performed to determine the number of viable cells in this assay.B riefly,2 10 4 cells suspended in DMEM (200 mL) were first inoculated into each well of a 96-well microplate and were incubated for 24 h. Then, the medium in each well was removed and an equal volume of serum-free medium (200 mLwell
À1
)c ontaining either test compound or positive control (doxorubicin hydrochloride, DOX) at various concentrations was added for 72 h. Each compound was performed in triplicate. Afterwards, the cell viability was determined by removing 100 mLo fm edium and adding 20 mLo fM TT solution (5 mg mL À1 in PBS) followed by 2h of incubation. Finally,D MEM with MTT solution was then removed and replaced with DMSO to dissolve the formazan crystal. The 96-well microplate was then measured at l = 570 nm by using aS pectramax (Molecular Devices) microplate spectrophotometer.F or data analysis, the percentage of surviving cells after exposure to various concentrations of each test compound for 72 hw as calculated to obtain the IC 50 value of each compound.
Protein Content (SRB) Analysis
The SRB assay is based on the measurement of cellular proteins. Sulforhodamine Bc an bind electrostatically with basic amino acid residues if the cells are fixed with trichloroacetic acid (TCA) and can be solubilized by weak bases. Because of this quantitative staining capacity of SRB, the assay is used to screen for cytotoxicity and cell density.T he cells were seeded at ac oncentration of 2 10 4 cells per well for 24 ha nd were treated with or without (control) compounds. Three days after this treatment, the cells were fixed by adding 50 %T CA in Milli-Q water (50 mL) for 1h in the cold room, 4 8C. The plate was washed at least three times with tap water and was then dried, after which the cells were stained with SRB solution (0.4 %s ulforhodamine Bi n1 %g lacial acetic acid) at 4 8C. After 30 min, the plate was rinsed with 1% glacial acetic acid (5 )d ried. Sequentially,T ris buffer in ac oncentration of 10 mm was used to redissolve the stain. Finally,t he absorbance was measured using the microplate spectrophotometer at aw avelength of 490 nm. Each condition was performed in triplicate.
Reactive Oxygen Species( ROS) Assay
The experiments were performed in an incubator at 37 8Cw ith 10 %C O 2 .S eeding of ac oncentration of 2 10 4 cells per well in DMEM was performed in ab lack 96-well plate with transparent bottom. After 24 h, the confluent cells were equally treated with or without the compounds at 10 and 1 mm in serum-free medium (200 mL). Then, after removal of the medium, the cells were washed with PBS buffer followed by the addition of 2,7-dichlorofluorescein diacetate (DCFH-DA, 20 mm)f or a3 0min incubation period. Thereafter,D CFH-DA was removed, and the cells were washed with PBS. Afterwards, DMEM without phenol red medium was added in equal volume for 1hof incubation. Finally,t he black 96-well plates were measured for fluorescence with aG emini XPS Microplate Reader with an excitation of l = 485 nm and an emission of l = 535 nm. Afterwards, the plate experiments were continued to evaluate the protein content with as imilar protocol as for the SRB assay described above. The SRB assay was used to normalize the results, which were related to the amount of protein present in each well.
Chemical Antioxidant Capacity: DPPH Scavenger
The 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical is commonly used to determine antioxidant activity.F irst, DPPH was freshly prepared at 5mgmL À1 in DMSO. Then, DPPH was diluted into 200 mm in MeOH for antioxidant measurements. In addition, stock solutions of test compounds were also properly diluted in MeOH at various concentrations. Afterwards, 200 mm DPPH solution (100 mL) was then added into 96-well microplates. Subsequently,t est compound (100 mL) at various concentrations and blanks without derivative were individually added into each well and vigorously mixed for 30 min in the dark chamber at 30 8C. After incubation in darkness, the solutions were measured at l = 515 nm by using aS pectramax microplate spectrophotometer.T he required concentration to reduce the absorbance by 50 %( EC 50 )w as calculated from the equation obtained by fitting the linear part of the absorption curves. Ap ositive compound, namely,T rolox, was used as reference. The results are the mean values determined from at least three independent experiments for each compound [Eq. (1) 
Ferric Reducing Ability of Plasma (FRAP) Assay
An acetate buffer of 300 mm was prepared by adding sodium acetate trihydrate (3.1 g) to acetic acid (16 mL) and was diluted to 1000 mL with Milli-Q water.ATPTZ (2,4,6-tripyridyl-s-triazine) solution of 10 mm was prepared by adding TPTZ (0.156 g) to ethanol (50 mL). Lastly,a2 0mm solution of iron(III) chloride hexahydrate was prepared by mixing FeCl 3 ·6H 2 O( 0.5404 g) with 37 %H Cl (2 mL) and Milli-Q water (98 mL). The TPTZ and iron solutions were freshly prepared on the day of the assay.T hese three mixtures were added in a1 0:1:1r atio to obtain the FRAP reagent. Finally, samples (100 mL) were mixed with the FRAP reagent (900 mL) and after 4min the absorbance was measured at l = 593 nm with a Spectramax microplate spectrophotometer.T rolox was used as a standard, and the FRAP value was calculated as Trolox equivalent [mm]through linear regression of the Trolox standard curve.
Water Solubilityand Stability Measurements
The shake flask method is commonly used to measure aqueous solubility. [12] The test compounds were first measured for maximum absorbance by using the liquid chromatography (LC) technique using Ascentis Express C18, HPLC column 3cm 4.6 mm, 2.7 mm (LC method for 5min at flow rate 1mLmin À1 during the gradient elution). Afterwards, the standard curves were prepared from various concentrations of the test compounds. In this experiment, a sodium phosphate buffered solution at pH 6.8 was used to perform the solubility test of each b-enaminone compound. An excess amount of as olid compound was added into 1mLo ft he phos- phate-buffered solution (pH 6.8). The experiment was divided into two time points. The first one was fixed at 90 min under as onicator bath at 37 8Ca nd the second one at 30 min under as onicator bath at 37 8Cf ollowed by 23 ho fi ncubation at 300 rpm and sonication for another 30 min. Both time points of each sample were centrifuged at 14 000 rpm for 5min. Then, all compounds were filtered (0.2 mm) at 37 8C. Subsequently,t he solutions were diluted in DMSO to avoid precipitation of the compounds at room temperature. Each compound was individually measured at its maximum absorbance. Finally,t he solubility values were calculated from the linear equations of each standard curve. The experiment was independently triplicated.
